Advances in Toll-like receptor biology: Modes of activation by diverse stimuli

References

• Abdi J, Engels F, Garssen, J, Redegeld FA. (2011). Toll-like receptor-9 triggering modulates expression of alpha-4 integrin on human B lymphocytes and their adhesion to extracellular matrix proteins. Exp Hematol 39:927–33
   PubMed Web of Science ®Google Scholar
• Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, et al. (2004). The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113:565–7
   PubMed Web of Science ®Google Scholar
• Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732–8
   PubMed Web of Science ®Google Scholar
• Alvarado J, Taylor P, Castillo JR, Thomas LE. (2005). Interferon gamma bound to extracellular matrix changes the hyporesponsiveness to LPS in crypt but not villous intestinal epithelial cells. Immunol Lett 99:109–12
   PubMed Web of Science ®Google Scholar
• Anders HJ, Schaefer L. (2014). Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol 25:1387–400
   PubMed Web of Science ®Google Scholar
• Antia M, Baneyx G, Kubow KE, Vogel V. (2008). Fibronectin in aging extracellular matrix fibrils is progressively unfolded by cells and elicits an enhanced rigidity response. Faraday Discuss 139:229–49; discussion 309–25, 419–20
   PubMed Web of Science ®Google Scholar
• Arbour NC, Lorenz E, Schutte BC, et al. (2000). TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–91
   PubMed Web of Science ®Google Scholar
• Arribillaga L, Durantez M, Lozano T, et al. (2013). A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo. Biomed Res Int 2013:864720
   PubMedGoogle Scholar
• Aryan Z, Holgate ST, Radzioch D, Rezaei N. (2014). A new era of targeting the ancient gatekeepers of the immune system: Toll-like agonists in the treatment of allergic rhinitis and asthma. Int Arch Allergy Immunol 164:46–63
   PubMed Web of Science ®Google Scholar
• Ayada Y, Kusachi S, Murakami T, et al. (2001). Increased expression of biglycan mRNA in pressure-overloaded rat heart. Clin Exp Hypertens 23:633–43
   PubMed Web of Science ®Google Scholar
• Baba H, Ishiwata T, Takashi E, et al. (2001). Expression and localization of lumican in the ischemic and reperfused rat heart. Jpn Circ J 65:445–50
   PubMedGoogle Scholar
• Babelova A, Moreth K, Tsalastra-Greul W, et al. (2009). Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X receptors. J Biol Chem 284:24035–48
   PubMed Web of Science ®Google Scholar
• Barrera V, Skorokhod OA, Baci D, et al. (2011). Host fibrinogen stably bound to hemozoin rapidly activates monocytes via TLR-4 and CD11b/CD18-integrin: a new paradigm of hemozoin action. Blood 117:5674–82
   PubMed Web of Science ®Google Scholar
• Baumann CL, Aspalter IM, Sharif O, et al. (2010). CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med 207:2689–701
   PubMed Web of Science ®Google Scholar
• Bereczki E, Gonda S, Csont T, et al. (2007). Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study. J Proteome Res 6:854–61
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Tamaki Z, Wang W, et al. (2014). FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling. Sci Transl Med 6:232ra50
   PubMed Web of Science ®Google Scholar
• Bryant CE, Spring DR, Gangloff M, Gay NJ. (2010). The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8:8–14
   PubMed Web of Science ®Google Scholar
• Carlson EC, Lin M, Liu CY, et al. (2007). Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1. J Biol Chem 282:35502–9
   PubMed Web of Science ®Google Scholar
• Carpenter S, Wochal P, Dunne A, O'Neill LA. (2011). Toll-like receptor 3 (TLR3) signaling requires TLR4 interactor with leucine-rich REPeats (TRIL). J Biol Chem 286:38795–804
   PubMed Web of Science ®Google Scholar
• Casi G, Neri D. (2012). Antibody–drug conjugates: basic concepts, examples and future perspectives. J Control Release 161:422–8
   PubMed Web of Science ®Google Scholar
• Casrouge A, Zhang SY, Eidenschenk C, et al. (2006). Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308–12
   PubMed Web of Science ®Google Scholar
• Chan JK, Roth J, Oppenheim JJ, et al. (2012). Alarmins: awaiting a clinical response. J Clin Invest 122:2711–19
   PubMed Web of Science ®Google Scholar
• Chapman MD, Pomes A, Breiteneder H, Ferreira F. (2007). Nomenclature and structural biology of allergens. J Allergy Clin Immunol 119:414–20
   PubMed Web of Science ®Google Scholar
• Chen S, Birk DE. (2013). The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J 280:2120–37
   PubMed Web of Science ®Google Scholar
• Cheng G, Swaidani S, Sharma M, et al. (2013). Correlation of hyaluronan deposition with infiltration of eosinophils and lymphocytes in a cockroach-induced murine model of asthma. Glycobiology 23:43–58
   PubMed Web of Science ®Google Scholar
• Chiquet-Ehrismann R, Orend G, Chiquet M, et al. (2014). Tenascins in stem cell niches. Matrix Biol 37:112–23
   PubMed Web of Science ®Google Scholar
• Chockalingam A, Brooks JC, Cameron JL, et al. (2009). TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol Cell Biol 87:209–17
   PubMed Web of Science ®Google Scholar
• Chung KJ, Mitroulis I, Wiessner JR, et al. (2014). A novel pathway of rapid TLR-triggered activation of integrin-dependent leukocyte adhesion that requires Rap1 GTPase. Mol Biol Cell 25:2948–55
   PubMed Web of Science ®Google Scholar
• Csont T, Gorbe A, Bereczki E, et al. (2010). Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J Mol Cell Cardiol 48:649–52
   PubMed Web of Science ®Google Scholar
• De Bouteiller O, Merck E, Hasan UA, et al. (2005). Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 280:38133–45
   PubMed Web of Science ®Google Scholar
• De Haan JJ, Smeets MB, Pasterkamp G, Arslan F. (2013). Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm 2013:206039
   PubMed Web of Science ®Google Scholar
• Demaria O, Pagni PP, Traub S, et al. (2010). TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 120:3651–62
   PubMed Web of Science ®Google Scholar
• Diebold SS, Kaisho T, Hemmi H, et al. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–31
   PubMed Web of Science ®Google Scholar
• Doll F, Schwager K, Hemmerle T, Neri D. (2013). Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse. Arthritis Res Ther 15:R138
   PubMed Web of Science ®Google Scholar
• Doz E, Rose S, Nigou J, et al. (2007). Acylation determines the Toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J Biol Chem 282:26014–25
   PubMed Web of Science ®Google Scholar
• Eberle F, Sirin M, Binder M, Dalpke AH. (2009). Bacterial RNA is recognized by different sets of immunoreceptors. Eur J Immunol 39:2537–47
   PubMed Web of Science ®Google Scholar
• Eder W, Klimecki W, Yu L, et al. (2004). Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113:482–8
   PubMed Web of Science ®Google Scholar
• Edwards L, Ferenczy A, Eron L, et al. (1998). Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol 134:25–30
   PubMed Web of Science ®Google Scholar
• El-Omar EM, Ng MT, Hold GL. (2008). Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 27:244–52
   PubMed Web of Science ®Google Scholar
• Ewald SE, Engel A, Lee J, et al. (2011). Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J Exp Med 208:643–51
   PubMed Web of Science ®Google Scholar
• Ewald SE, Lee BL, Lau L, et al. (2008). The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456:658–62
   PubMed Web of Science ®Google Scholar
• Fabbri M, Paone A, Calore F, et al. (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 109:E2110–16
   PubMed Web of Science ®Google Scholar
• Frantz S, Kobzik L, Kim YD, et al. (1999). Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104:271–80
   PubMed Web of Science ®Google Scholar
• Frey H, Schroeder N, Manon-Jensen T, et al. (2013). Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J 280:2165–79
   PubMed Web of Science ®Google Scholar
• Fujimoto M, Suzuki H, Shiba M, et al. (2013). Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol Dis 55:104–9
   PubMed Web of Science ®Google Scholar
• Fukui R, Saitoh S, Matsumoto F, et al. (2009). Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 206:1339–50
   PubMed Web of Science ®Google Scholar
• Gangloff M, Gay NJ. (2004). MD-2: the Toll ‘gatekeeper' in endotoxin signalling. Trends Biochem Sci 29:294–300
   PubMed Web of Science ®Google Scholar
• Ganguly D, Chamilos G, Lande R, et al. (2009). Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206:1983–94
   PubMed Web of Science ®Google Scholar
• Gay NJ, Gangloff M, O'Neill LA. (2011). What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 32:104–9
   PubMed Web of Science ®Google Scholar
• Gay NJ, Gangloff M. (2007). Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76:141–65
   PubMed Web of Science ®Google Scholar
• Geisse J, Caro I, Lindholm J, et al. (2004). Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50:722–33
   PubMed Web of Science ®Google Scholar
• Gibbard RJ, Morley PJ, Gay NJ. (2006). Conserved features in the extracellular domain of human Toll-like receptor 8 are essential for pH-dependent signaling. J Biol Chem 281:27503–11
   PubMed Web of Science ®Google Scholar
• Goh FG, Piccinini AM, Krausgruber T, et al. (2010). Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 184:2655–62
   PubMed Web of Science ®Google Scholar
• Gondokaryono SP, Ushio H, Niyonsaba F, et al. (2007). The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4. J Leukoc Biol 82:657–65
   PubMed Web of Science ®Google Scholar
• Gorden KK, Qiu XX, Binsfeld CC, et al. (2006). Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol 177:6584–7
   PubMed Web of Science ®Google Scholar
• Govindaraj RG, Manavalan B, Basith S, Choi S. (2011). Comparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesis. PLoS One 6:e25118
   PubMed Web of Science ®Google Scholar
• Green DS, Bodman-Smith MD, Dalgleish AG, Fischer MD. (2007). Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma. Br J Dermatol 156:337–45
   PubMed Web of Science ®Google Scholar
• Guo Y, Audry M, Ciancanelli M, et al. (2011). Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med 208:2083–98
   PubMed Web of Science ®Google Scholar
• Haas T, Metzger J, Schmitz F, et al. (2008). The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 28: 315–23
   PubMed Web of Science ®Google Scholar
• Hacker G, Redecke V, Hacker H. (2002). Activation of the immune system by bacterial CpG-DNA. Immunology 105:245–51
   PubMed Web of Science ®Google Scholar
• Haglund L, Bernier SM, Onnerfjord P, Recklies AD. (2008). Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biol 27:107–18
   PubMed Web of Science ®Google Scholar
• Hammad H, Chieppa M, Perros F, et al. (2009). House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 15:410–16
   PubMed Web of Science ®Google Scholar
• Hao J, Ju H, Zhao S, et al. (1999). Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing. J Mol Cell Cardiol 31:667–78
   PubMed Web of Science ®Google Scholar
• Heil F, Hemmi H, Hochrein H, et al. (2004). Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526–9
   PubMed Web of Science ®Google Scholar
• Hemmerle T, Doll F, Neri D. (2014). Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. Proc Natl Acad Sci USA 111:12008–12
   PubMed Web of Science ®Google Scholar
• Hemmi H, Kaisho T, Takeuchi O, et al. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196–200
   PubMed Web of Science ®Google Scholar
• Henderson B, Nair S, Pallas J, Williams MA. (2011). Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol Rev 35:147–200
   PubMed Web of Science ®Google Scholar
• Hennessy EJ, Parker AE, O'Neill LA. (2010). Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9:293–307
   PubMed Web of Science ®Google Scholar
• Hepburn L, Prajsnar TK, Klapholz C, et al. (2014). Innate immunity. A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus. Science 346:641–6
   PubMed Web of Science ®Google Scholar
• Herre J, Gronlund H, Brooks H, et al. (2013). Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands. J Immunol 191:1529–35
   PubMed Web of Science ®Google Scholar
• Hidaka F, Matsuo S, Muta T, et al. (2006). A missense mutation of the Toll-like receptor 3 gene in a patient with influenza-associated encephalopathy. Clin Immunol 119:188–94
   PubMed Web of Science ®Google Scholar
• Higashikuni Y, Tanaka K, Kato M, et al. (2013). Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1beta upregulation via nuclear factor kappaB activation. J Am Heart Assoc 2:e000267
   PubMed Web of Science ®Google Scholar
• Hocking AM, Shinomura T, Mcquillan DJ. (1998). Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 17:1–19
   PubMed Web of Science ®Google Scholar
• Hodgkinson CP, Patel K, Ye S. (2008). Functional Toll-like receptor 4 mutations modulate the response to fibrinogen. Thromb Haemost 100:301–7
   PubMed Web of Science ®Google Scholar
• Horak F. (2011). VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis. Expert Opin Invest Drugs 20:981–6
   PubMed Web of Science ®Google Scholar
• Hsieh LT, Nastase MV, Zeng-Brouwers J, et al. (2014). Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol 54:223–35
   PubMed Web of Science ®Google Scholar
• Huang J, Xie Y, Sun X, et al. (2014). DAMPs, ageing, and cancer: the ‘DAMP Hypothesis'. Ageing Res Rev. [Epub ahead of print]. doi:10.1016/j.arr.2014.10.004
   PubMed Web of Science ®Google Scholar
• Huh JW, Shibata T, Hwang M, et al. (2014). UNC93B1 is essential for the plasma membrane localization and signaling of Toll-like receptor 5. Proc Natl Acad Sci USA 111:7072–7
   PubMed Web of Science ®Google Scholar
• Ibrahim ZA, Armour CL, Phipps S, Sukkar MB. (2013). RAGE and TLRs: relatives, friends or neighbours? Mol Immunol 56:739–44
   PubMed Web of Science ®Google Scholar
• Inohara N, Nunez G. (2002). ML – a conserved domain involved in innate immunity and lipid metabolism. Trends Biochem Sci 27:219–21
   PubMed Web of Science ®Google Scholar
• Iozzo RV, Schaefer L. (2010). Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J 277:3864–75
   PubMed Web of Science ®Google Scholar
• Ishii N, Funami K, Tatematsu M, et al. (2014). Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells. J Immunol 193:5118–28
   PubMed Web of Science ®Google Scholar
• Itoh H, Tatematsu M, Watanabe A, et al. (2011). UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS One 6:e28500
   PubMed Web of Science ®Google Scholar
• Ivanov S, Dragoi AM, Wang X, et al. (2007). A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110:1970–81
   PubMed Web of Science ®Google Scholar
• Ivicak-Kocjan K, Panter G, Bencina M, Jerala R. (2013). Determination of the physiological 2:2 TLR5:flagellin activation stoichiometry revealed by the activity of a fusion receptor. Biochem Biophys Res Commun 435:40–5
   PubMed Web of Science ®Google Scholar
• Jahanyar J, Joyce DL, Southard RE, et al. (2007). Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant 26:34–40
   PubMed Web of Science ®Google Scholar
• Jelinek I, Leonard JN, Price GE, et al. (2011). TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 186:2422–9
   PubMed Web of Science ®Google Scholar
• Jin MS, Kim SE, Heo JY, et al. (2007). Crystal structure of the TLR1–TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071–82
   PubMed Web of Science ®Google Scholar
• Kaiser L, Gronlund H, Sandalova T, et al. (2003). The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem 278:37730–5
   PubMed Web of Science ®Google Scholar
• Kang JY, Nan X, Jin MS, et al. (2009). Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873–84
   PubMed Web of Science ®Google Scholar
• Kang R, Chen R, Zhang Q, et al. (2014). HMGB1 in health and disease. Mol Aspects Med 40C:1–116
   Google Scholar
• Kanno A, Yamamoto C, Onji M, et al. (2013). Essential role for Toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing. Int Immunol 25:413–22
   PubMed Web of Science ®Google Scholar
• Kariko K, Bhuyan P, Capodici J, et al. (2004a). Exogenous siRNA mediates sequence-independent gene suppression by signaling through Toll-like receptor 3. Cells Tissues Organs 177:132–8
   PubMed Web of Science ®Google Scholar
• Kariko K, Ni H, Capodici J, et al. (2004b). mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 279:12542–50
   PubMed Web of Science ®Google Scholar
• Kelsh RM, Mckeown-Longo PJ. (2013). Topographical changes in extracellular matrix: activation of TLR4 signaling and solid tumor progression. Trends Cancer Res 9:1–13
   PubMedGoogle Scholar
• Kelsh R, You R, Horzempa C, et al. (2014). Regulation of the innate immune response by fibronectin: synergism between the III-1 and EDA domains. PLoS One 9:e102974
   PubMed Web of Science ®Google Scholar
• Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. (2008). UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature 452:234–8
   PubMed Web of Science ®Google Scholar
• Kim JY, Choung S, Lee EJ, et al. (2007). Immune activation by siRNA/liposome complexes in mice is sequence-independent: lack of a role for Toll-like receptor 3 signaling. Mol Cells 24:247–54
   PubMed Web of Science ®Google Scholar
• Kormann MS, Depner M, Hartl D, et al. (2008). Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 122:86–92, 92e1–8
   PubMed Web of Science ®Google Scholar
• Krieg AM, Yi AK, Matson S, et al. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–9
   PubMed Web of Science ®Google Scholar
• Krug A, Luker GD, Barchet W, et al. (2004). Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103:1433–7
   PubMed Web of Science ®Google Scholar
• Kuhns DB, Priel DA, Gallin JI. (2007). Induction of human monocyte interleukin (IL)-8 by fibrinogen through the Toll-like receptor pathway. Inflammation 30:178–88
   PubMed Web of Science ®Google Scholar
• Kulka M, Metcalfe DD. (2006). TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 43:1579–86
   PubMed Web of Science ®Google Scholar
• Kuriyama N, Duarte S, Hamada T, et al. (2011). Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Hepatology 54:2125–36
   PubMed Web of Science ®Google Scholar
• Lande R, Gregorio J, Facchinetti V, et al. (2007). Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449:564–9
   PubMed Web of Science ®Google Scholar
• Lasarte JJ, Casares N, Gorraiz M, et al. (2007). The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 178:748–56
   PubMed Web of Science ®Google Scholar
• Latz E, Schoenemeyer A, Visintin A, et al. (2004). TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5:190–8
   PubMed Web of Science ®Google Scholar
• Latz E, Verma A, Visintin A, et al. (2007). Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8:772–9
   PubMed Web of Science ®Google Scholar
• Lee J, Chuang TH, Redecke V, et al. (2003). Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 100:6646–51
   PubMed Web of Science ®Google Scholar
• Lee HK, Dunzendorfer S, Soldau K, Tobias PS. (2006). Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity 24:153–63
   PubMed Web of Science ®Google Scholar
• Lee BL, Moon JE, Shu JH, et al. (2013). UNC93B1 mediates differential trafficking of endosomal TLRs. Elife 2:e00291
   PubMed Web of Science ®Google Scholar
• Lefebvre JS, Levesque T, Picard S, et al. (2011). Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum 63:1527–33
   PubMed Web of Science ®Google Scholar
• Lehmann SM, Kruger C, Park B, et al. (2012). An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15:827–35
   PubMed Web of Science ®Google Scholar
• Leonard JN, Ghirlando R, Askins J, et al. (2008). The TLR3 signaling complex forms by cooperative receptor dimerization. Proc Natl Acad Sci USA 105:258–63
   PubMed Web of Science ®Google Scholar
• Li Y, Berke IC, Modis Y. (2012). DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J 31:919–31
   PubMed Web of Science ®Google Scholar
• Li DQ, Zhang L, Pflugfelder SC, et al. (2011). Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol 128:1318–25
   PubMed Web of Science ®Google Scholar
• Liu L, Botos I, Wang Y, et al. (2008). Structural basis of Toll-like receptor 3 signaling with double-stranded RNA. Science 320:379–81
   PubMed Web of Science ®Google Scholar
• Liu R, He Y, Li B, et al. (2012). Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4. Mol Cells 34:35–41
   PubMed Web of Science ®Google Scholar
• Liu B, Yang Y, Qiu Z, et al. (2010). Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nat Commun 1:79
   PubMed Web of Science ®Google Scholar
• Lonez C, Irvine K, Pizzuto M, et al. (2014). Novel mechanism of TLR4 activation by cationic lipids. eLife 15:R111
   Google Scholar
• Lorenz W, Buhrmann C, Mobasheri A, et al. (2013). Bacterial lipopolysaccharides form procollagen-endotoxin complexes that trigger cartilage inflammation and degeneration: implications for the development of rheumatoid arthritis. Arthritis Res Ther 15:R111
   PubMed Web of Science ®Google Scholar
• Lund JM, Alexopoulou L, Sato A, et al. (2004). Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 101:5598–603
   PubMed Web of Science ®Google Scholar
• Magna M, Pisetsky DS. (2014). The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol Med 20:138–46
   PubMed Web of Science ®Google Scholar
• Maisonneuve C, Bertholet S, Philpott DJ, De Gregorio E. (2014). Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants. Proc Natl Acad Sci USA 111:12294–9
   PubMed Web of Science ®Google Scholar
• Martinez FD. (2007). CD14, endotoxin, and asthma risk: actions and interactions. Proc Am Thorac Soc 4:221–5
   PubMedGoogle Scholar
• Matijevic T, Pavelic J. (2011). The dual role of TLR3 in metastatic cell line. Clin Exp Metastasis 28:701–12
   PubMed Web of Science ®Google Scholar
• Mcilroy G, Foldi I, Aurikko J, et al. (2013). Toll-6 and Toll-7 function as neurotrophin receptors in the Drosophila melanogaster CNS. Nat Neurosci 16:1248–56
   PubMed Web of Science ®Google Scholar
• Medeiros DM, Velleman SG, Jarrold BB, et al. (2002). Ontogeny of enhanced decorin levels and distribution within myocardium of failing hearts. Connect Tissue Res 43:32–43
   PubMed Web of Science ®Google Scholar
• Meirovitz A, Goldberg R, Binder A, et al. (2013). Heparanase in inflammation and inflammation-associated cancer. FEBS J 280:2307–19
   PubMed Web of Science ®Google Scholar
• Meng J, Lien E, Golenbock DT. (2009). MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation. J Biol Chem 285:8695–702
   PubMed Web of Science ®Google Scholar
• Merline R, Lazaroski S, Babelova A, et al. (2009a). Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. J Physiol Pharmacol 60:5–13
   PubMed Web of Science ®Google Scholar
• Merline R, Moreth K, Beckmann J, et al. (2011). Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal 4:ra75
   PubMed Web of Science ®Google Scholar
• Merline R, Schaefer RM, Schaefer L. (2009b). The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal 3:323–35
   PubMed Web of Science ®Google Scholar
• Mickiene A, Pakalniene J, Nordgren J, et al. (2014). Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the lithuanian population. PLoS One 9:e106798
   PubMed Web of Science ®Google Scholar
• Midwood K, Sacre S, Piccinini AM, et al. (2009a). Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15:774–80
   PubMed Web of Science ®Google Scholar
• Midwood KS, Piccinini AM, Sacre, S. (2009b). Targeting Toll-like receptors in autoimmunity. Curr Drug Targets 10:1139–55
   PubMed Web of Science ®Google Scholar
• Millien VO, Lu W, Shaw J, et al. (2013). Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science 341:792–6
   PubMed Web of Science ®Google Scholar
• Mogami H, Keller PW, Shi H, Word RA. (2014). Effect of thrombin on human amnion mesenchymal cells, mouse fetal membranes, and preterm birth. J Biol Chem 289:13295–307
   PubMed Web of Science ®Google Scholar
• Monick MM, Powers L, Butler N, et al. (2002). Interaction of matrix with integrin receptors is required for optimal LPS-induced MAP kinase activation. Am J Physiol Lung Cell Mol Physiol 283:L390–402
   PubMed Web of Science ®Google Scholar
• Moreth K, Brodbeck R, Babelova A, et al. (2010). The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest 120:4251–72
   PubMed Web of Science ®Google Scholar
• Moreth K, Frey H, Hubo M, et al. (2014). Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 35:143–51
   PubMed Web of Science ®Google Scholar
• Moreth K, Iozzo RV, Schaefer L. (2012). Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 11:2084–91
   PubMed Web of Science ®Google Scholar
• Motojima M, Matsusaka T, Kon V, Ichikawa I. (2010). Fibrinogen that appears in Bowman's space of proteinuric kidneys in vivo activates podocyte Toll-like receptors 2 and 4 in vitro. Nephron Exp Nephrol 114:e39–47
   PubMed Web of Science ®Google Scholar
• Murakami Y, Fukui R, Motoi Y, et al. (2014). Roles of the cleaved N-terminal TLR3 fragment and cell surface TLR3 in double-strand RNA sensing. J Immunol 193:5208–17
   PubMed Web of Science ®Google Scholar
• Nagai Y, Akashi S, Nagafuku M, et al. (2002a). Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3:667–72
   PubMed Web of Science ®Google Scholar
• Nagai Y, Shimazu R, Ogata H, et al. (2002b). Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99:1699–705
   PubMed Web of Science ®Google Scholar
• Nastase MV, Iozzo RV, Schaefer L. (2014). Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta 1840:2460–70
   PubMed Web of Science ®Google Scholar
• Nastase MV, Young MF, Schaefer L. (2012). Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem 60:963–75
   PubMed Web of Science ®Google Scholar
• Neill T, Schaefer L, Iozzo RV. (2012). Decorin: a guardian from the matrix. Am J Pathol 181:380–7
   PubMed Web of Science ®Google Scholar
• Oh DY, Taube S, Hamouda O, et al. (2008). A functional Toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 198:701–9
   PubMed Web of Science ®Google Scholar
• Okahira S, Nishikawa F, Nishikawa S, et al. (2005). Interferon-beta induction through Toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell Biol 24:614–23
   PubMed Web of Science ®Google Scholar
• Okamura Y, Watari M, Jerud ES, et al. (2001). The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276:10229–33
   PubMed Web of Science ®Google Scholar
• O'Neill LA, Bryant CE, Doyle SL. (2009). Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev 61:177–97
   PubMed Web of Science ®Google Scholar
• Onji M, Kanno A, Saitoh S, et al. (2013). An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nat Commun 4:1949. doi:10.1038/ncomms2949
   PubMed Web of Science ®Google Scholar
• Pal D, Dasgupta S, Kundu R, et al. (2012). Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 18:1279–85
   PubMed Web of Science ®Google Scholar
• Park B, Brinkmann MM, Spooner E, et al. (2008). Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9:1407–14
   PubMed Web of Science ®Google Scholar
• Park B, Buti L, Lee S, et al. (2011). Granulin is a soluble cofactor for Toll-like receptor 9 signaling. Immunity 34:505–13
   PubMed Web of Science ®Google Scholar
• Park BS, Song DH, Kim HM, et al. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458:1191–5
   PubMed Web of Science ®Google Scholar
• Patel L, Sun W, Glasson SS, et al. (2011). Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet Disord 12:164
   PubMed Web of Science ®Google Scholar
• Pelka K, Phulphagar K, Zimmermann J, et al. (2014). Cutting Edge: the UNC93B1 tyrosine-based motif regulates trafficking and TLR responses via separate mechanisms. J Immunol 193:3257–61
   PubMed Web of Science ®Google Scholar
• Petretto E, Sarwar R, Grieve I, et al. (2008). Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet 40:546–52
   PubMed Web of Science ®Google Scholar
• Petrey AC, De La Motte CA. (2014). Hyaluronan, a crucial regulator of inflammation. Front Immunol 5:101. doi:10.3389/fimmu.2014.00101
   PubMed Web of Science ®Google Scholar
• Piccinini AM, Midwood KS. (2010). DAMPening inflammation by modulating TLR signalling. Mediators Inflamm 2010:672395. doi:10.1155/2010/672395
   Google Scholar
• Piccinini AM, Midwood KS. (2012). Endogenous control of immunity against infection: tenascin-C regulates TLR4-mediated inflammation via microRNA-155. Cell Rep 2:914–26
   PubMed Web of Science ®Google Scholar
• Pohar J, Pirher N, Bencina M, et al. (2013). The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. J Biol Chem 288:442–54
   PubMed Web of Science ®Google Scholar
• Popa C, Van Lieshout AW, Roelofs MF, et al. (2006). MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis. Cytokine 36:51–6
   PubMed Web of Science ®Google Scholar
• Popovic ZV, Wang S, Papatriantafyllou M, et al. (2011). The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol 187:6217–26
   PubMed Web of Science ®Google Scholar
• Raby AC, Holst B, Le Bouder E, et al. (2013). Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Transl Med 5:185ra64
   PubMed Web of Science ®Google Scholar
• Raghavan B, Martin SF, Esser PR, et al. (2012). Metal allergens nickel and cobalt facilitate TLR4 homodimerization independently of MD2. EMBO Rep 13:1109–15
   PubMed Web of Science ®Google Scholar
• Resman N, Vasl J, Oblak A, et al. (2009). Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 284:15052–60
   Google Scholar
• Ribes S, Ebert S, Regen T, et al. (2010). Fibronectin stimulates Escherichia coli phagocytosis by microglial cells. Glia 58:367–76
   PubMed Web of Science ®Google Scholar
• Rigby RE, Webb LM, Mackenzie KJ, et al. (2014). RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J 33:542–58
   PubMed Web of Science ®Google Scholar
• Roberts BJ, Moussawi M, Huber SA. (2013). Sex differences in TLR2 and TLR4 expression and their effect on coxsackievirus-induced autoimmune myocarditis. Exp Mol Pathol 94:58–64
   PubMed Web of Science ®Google Scholar
• Rock FL, Hardiman G, Timans JC, et al. (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588–93
   PubMed Web of Science ®Google Scholar
• Roelofs MF, Abdollahi-Roodsaz S, Joosten LA, et al. (2008). The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum 58:338–48
   PubMed Web of Science ®Google Scholar
• Ross MA, Curtis L, Scheff PA, et al. (2000). Association of asthma symptoms and severity with indoor bioaerosols. Allergy 55:705–11
   PubMed Web of Science ®Google Scholar
• Rudd BD, Burstein E, Duckett CS, et al. (2005). Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 79:3350–7
   PubMed Web of Science ®Google Scholar
• Ruppert SM, Hawn TR, Arrigoni A, et al. (2014). Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol Res 58:186–92
   PubMed Web of Science ®Google Scholar
• Rutz M, Metzger J, Gellert T, et al. (2004). Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol 34:2541–50
   PubMed Web of Science ®Google Scholar
• Ryu JH, Yoo JY, Kim MJ, et al. (2013). Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways. J Allergy Clin Immunol 131:549–61
   PubMed Web of Science ®Google Scholar
• Sakata Y, Dong JW, Vallejo JG, et al. (2007). Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292:H503–9
   PubMed Web of Science ®Google Scholar
• Sasai M, Linehan MM, Iwasaki A. (2010). Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329:1530–4
   PubMed Web of Science ®Google Scholar
• Satoh M, Shimoda Y, Maesawa C, et al. (2006). Activated Toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 109:226–34
   PubMed Web of Science ®Google Scholar
• Savarese E, Chae OW, Trowitzsch S, et al. (2006). U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107:3229–34
   PubMed Web of Science ®Google Scholar
• Schaefer L. (2014). Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem 289:35237–45
   Google Scholar
• Schaefer L, Babelova A, Kiss E, et al. (2005). The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223–33
   PubMed Web of Science ®Google Scholar
• Schaefer L, Iozzo RV. (2008). Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305–9
   PubMed Web of Science ®Google Scholar
• Schaefer L, Iozzo RV. (2012). Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr Opin Genet Dev 22:56–7
   PubMed Web of Science ®Google Scholar
• Schaefer L, Macakova K, Raslik I, et al. (2002). Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160:1181–91
   PubMed Web of Science ®Google Scholar
• Schaefer L, Raslik I, Grone HJ, et al. (2001). Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J 15:559–61
   PubMed Web of Science ®Google Scholar
• Schmidt M, Raghavan B, Muller V, et al. (2010). Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol 11:814–19
   PubMed Web of Science ®Google Scholar
• Shishido T, Nozaki N, Yamaguchi S, et al. (2003). Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 108:2905–10
   PubMed Web of Science ®Google Scholar
• Smiley ST, King JA, Hancock WW. (2001). Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol 167:2887–94
   PubMed Web of Science ®Google Scholar
• Sokolove J, Zhao X, Chandra PE, Robinson WH. (2011). Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum 63:53–62
   PubMed Web of Science ®Google Scholar
• Sorensen I, Susnik N, Inhester T, et al. (2011). Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 80:1035–44
   PubMed Web of Science ®Google Scholar
• Spitzauer S. (1999). Allergy to mammalian proteins: at the borderline between foreign and self? Int Arch Allergy Immunol 120:259–69
   PubMed Web of Science ®Google Scholar
• Suwarti S, Yamazaki T, Svetlana C, Hanagata N. (2013). Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction. Biochem Biophys Res Commun 430:1234–9
   PubMed Web of Science ®Google Scholar
• Takahashi K, Shibata T, Akashi-Takamura S, et al. (2007). A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204:2963–76
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Coyne CB, et al. (2012). PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 249:158–75
   PubMed Web of Science ®Google Scholar
• Tanji H, Ohto U, Shibata T, et al. (2013). Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339:1426–9
   PubMed Web of Science ®Google Scholar
• Tatematsu M, Nishikawa F, Seya T, Matsumoto M. (2013). Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat Commun 4:1833. doi:10.1038/ncomms2857
   PubMed Web of Science ®Google Scholar
• Telepnev MV, Klimpel GR, Haithcoat J, et al. (2009). Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells. J Infect Dis 200:1694–702
   PubMed Web of Science ®Google Scholar
• Timmers L, Sluijter JP, Van Keulen JK, et al. (2008). Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 102:257–64
   PubMed Web of Science ®Google Scholar
• To WS, Midwood KS. (2011). Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair 4:21. doi:10.1186/1755-1536-4-21
   PubMedGoogle Scholar
• Trompette A, Divanovic S, Visintin A, et al. (2009). Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457:585–8
   PubMed Web of Science ®Google Scholar
• Tsan MF, Gao B. (2009). Heat shock proteins and immune system. J Leukoc Biol 85:905–10
   PubMed Web of Science ®Google Scholar
• Tsui FW, Xi N, Rohekar S, et al. (2008). Toll-like receptor 2 variants are associated with acute reactive arthritis. Arthritis Rheum 58:3436–8
   PubMed Web of Science ®Google Scholar
• Udalova IA, Ruhmann M, Thomson SJ, Midwood KS. (2011). Expression and immune function of tenascin-C. Crit Rev Immunol 31:115–45
   PubMed Web of Science ®Google Scholar
• Vacchelli E, Eggermont A, Sautes-Fridman C, et al. (2013). Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology 2:e25238
   PubMed Web of Science ®Google Scholar
• Vanhoutte D, Van Almen GC, Van Aelst LN, et al. (2013). Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection. Eur Heart J 34:1930–41
   PubMed Web of Science ®Google Scholar
• Viglianti GA, Lau CM, Hanley TM, et al. (2003). Activation of autoreactive B cells by CpG dsDNA. Immunity 19:837–47
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Kobayashi M, Akashi-Takamura S, et al. (2006). A protein associated with Toll-like receptor 4 (PRAT4A) regulates cell surface expression of TLR4. J Immunol 177:1772–9
   PubMed Web of Science ®Google Scholar
• Walsh C, Gangloff M, Monie T, et al. (2008). Elucidation of the MD-2/TLR4 interface required for signaling by lipid IVa. J Immunol 181:1245–54
   PubMed Web of Science ®Google Scholar
• Wang T, Town T, Alexopoulou L, et al. (2004). Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366–73
   PubMed Web of Science ®Google Scholar
• Weber A, Tauszig-Delamasure S, Hoffmann J, et al. (2003). Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signaling. Nat Immunol 4:794–800
   PubMed Web of Science ®Google Scholar
• Weber C, Muller C, Podszuweit A, et al. (2012). Toll-like receptor (TLR) 3 immune modulation by unformulated small interfering RNA or DNA and the role of CD14 (in TLR-mediated effects). Immunology 136:64–77
   PubMed Web of Science ®Google Scholar
• Wiertsema SP, Khoo SK, Baynam G, et al. (2006). Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses. Clin Vaccine Immunol 13:892–7
   PubMed Web of Science ®Google Scholar
• Williams KJ, Qiu G, Usui HK, et al. (2007). Decorin deficiency enhances progressive nephropathy in diabetic mice. Am J Pathol 171:1441–50
   PubMed Web of Science ®Google Scholar
• Wilson RH, Maruoka S, Whitehead GS, et al. (2012). The Toll-like receptor 5 ligand flagellin promotes asthma by priming allergic responses to indoor allergens. Nat Med 18:1705–10
   PubMed Web of Science ®Google Scholar
• Wolberg AS. (2012). Determinants of fibrin formation, structure, and function. Curr Opin Hematol 19:349–56
   PubMed Web of Science ®Google Scholar
• Wu F, Vij N, Roberts L, et al. (2007). A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response. J Biol Chem 282:26409–17
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Mann DM, Ruoslahti E. (1990). Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346:281–4
   PubMed Web of Science ®Google Scholar
• Yan W, Wang P, Zhao CX, et al. (2009). Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways. Hum Gene Ther 20:1190–200
   PubMed Web of Science ®Google Scholar
• Yanai H, Ban T, Wang Z, et al. (2009). HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462:99–103
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu B, Dai J, et al. (2007). Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26:215–26
   PubMed Web of Science ®Google Scholar
• Yoon SI, Kurnasov O, Natarajan V, et al. (2012). Structural basis of TLR5-flagellin recognition and signaling. Science 335:859–64
   PubMed Web of Science ®Google Scholar
• Yoshida H, Nishikawa M, Yasuda S, et al. (2012). Fibronectin inhibits cytokine production induced by CpG DNA in macrophages without direct binding to DNA. Cytokine 60:162–70
   PubMed Web of Science ®Google Scholar
• You R, Zheng M, Mckeown-Longo PJ. (2010). The first type III repeat in fibronectin activates an inflammatory pathway in dermal fibroblasts. J Biol Chem 285:36255–9
   PubMed Web of Science ®Google Scholar
• Yu L, Wang L, Chen S. (2010). Endogenous Toll-like receptor ligands and their biological significance. J Cell Mol Med 14:2592–603
   PubMed Web of Science ®Google Scholar
• Zanin-Zhorov A, Tal-Lapidot G, Cahalon L, et al. (2007). Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J Immunol 179:41–4
   PubMed Web of Science ®Google Scholar
• Zeng-Brouwers J, Beckmann J, Nastase MV, et al. (2014). De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. Matrix Biol 35:132–42
   PubMed Web of Science ®Google Scholar
• Zhang SY, Jouanguy E, Ugolini S, et al. (2007). TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522–7
   PubMed Web of Science ®Google Scholar
• Zheng M, Jones DM, Horzempa C, et al. (2011). The first type III domain of fibronectin is associated with the expression of cytokines within the lung tumor microenvironment. J Cancer 2:478–83
   PubMed Web of Science ®Google Scholar
• Zhu J, Huang X, Yang Y. (2007). Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J Virol 81:3170–80
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zou L, Jagavelu K, et al. (2012). Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol 56:893–9
   PubMed Web of Science ®Google Scholar
• Zimmerman SD, Thomas DP, Velleman SG, et al. (2001). Time course of collagen and decorin changes in rat cardiac and skeletal muscle post-MI. Am J Physiol Heart Circ Physiol 281:H1816–22
   PubMed Web of Science ®Google Scholar